This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Barlas Buyuktimkin: Innovator in Autoimmune Disorder Treatments
Introduction
Barlas Buyuktimkin is a notable inventor based in Lawrence, Kansas, who has made significant contributions to the field of autoimmune disorder treatments. His innovative work focuses on developing compounds that can effectively interact with the immune system to provide therapeutic benefits.
Latest Patents
Barlas Buyuktimkin holds a patent for "Compositions including I-domain antigen conjugate compounds and methods for treatment of autoimmune disorders." This patent describes IDAC compounds that are capable of presenting two or more signal 1 moieties to a host immune system. The compounds include a modified I-domain peptide with multiple modified lysine residues and signal 1 moieties conjugated to these residues. The methods outlined in the patent aim to treat or prevent autoimmune disorders in subjects.
Career Highlights
Barlas Buyuktimkin is affiliated with the University of Kansas Medical Center Research Institute, where he conducts his research and development work. His focus on autoimmune disorders has positioned him as a key figure in this area of study.
Collaborations
Barlas has collaborated with notable colleagues such as Teruna J Siahaan and Prakash Manikwar, contributing to the advancement of research in his field.
Conclusion
Barlas Buyuktimkin's innovative work in developing treatments for autoimmune disorders showcases his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile